Collegium Pharmaceutical (NASDAQ: COLL) net income
Collegium Pharmaceutical reported a net profit of $62.9m for fiscal 2025, 9.1% less than in fiscal 2024 ($69.2m). Its net margin was 8.1%. Earnings per share were $1.98.
Collegium Pharmaceutical's best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2025, −9.1%. It reported a loss in 5 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $62.9m | −9.1% | 8.1% | $1.98 |
| 2024 | $69.2m | +43.7% | 11.0% | $2.14 |
| 2023 | $48.2m | — | 8.5% | $1.43 |
| 2022 | −$25.0m | −135.0% | −5.4% | −$0.74 |
| 2021 | $71.5m | +167.3% | 25.8% | $2.05 |
| 2020 | $26.8m | — | 8.6% | $0.78 |
| 2019 | −$22.7m | — | −7.7% | −$0.68 |
| 2018 | −$39.1m | — | −14.0% | −$1.19 |
| 2017 | −$74.9m | — | −262.9% | — |
| 2016 | −$94.2m | — | −5,504.1% | −$3.88 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Collegium Pharmaceutical net income compared with its sector
By net income for its latest fiscal year, Collegium Pharmaceutical ranks 127th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Collegium Pharmaceutical, 8.1%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 125th | Veracyte | $66.4m | 12.8% |
| 126th | Oramed Pharmaceuticals | $64.1m | 3,202.5% |
| 127th | Collegium Pharmaceutical | $62.9m | 8.1% |
| 128th | Healthcare Services Group | $59.1m | 3.2% |
| 129th | Kiniksa Pharmaceuticals International | $59.0m | 8.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Collegium Pharmaceutical
- How much did Collegium Pharmaceutical earn in fiscal 2025?
- Collegium Pharmaceutical reported a net profit of $62.9m for fiscal 2025. In fiscal 2024 it reported a net profit of $69.2m.
- What are the earnings per share of Collegium Pharmaceutical?
- They were $1.98 in fiscal 2025, compared with $2.14 in fiscal 2024.
- What is the net margin of Collegium Pharmaceutical?
- In fiscal 2025 its net profit was 8.1% of its revenue.
- What was the most profitable year for Collegium Pharmaceutical?
- Of its last 10 fiscal years, fiscal 2021, with $71.5m.
- Where does Collegium Pharmaceutical rank in its sector by net income?
- It ranks 127th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Collegium Pharmaceutical come from?
- From the annual report (Form 10-K) that Collegium Pharmaceutical files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Collegium Pharmaceutical files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Collegium Pharmaceutical: the Collegium Pharmaceutical page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.